TY - JOUR
T1 - Cytokines and autoimmunity
T2 - Redundancy defines their complex nature
AU - Yadav, Deepak
AU - Sarvetnick, Nora
PY - 2003/12
Y1 - 2003/12
N2 - Cytokines are critical mediators in autoimmunity and a better understanding of their mode of action should contribute to the development of strategies for controlling harmful autoimmune reactions. Their complicated nature makes it difficult to classify them as pro- or anti-inflammatory mediators; redundancy in their mode of action has been widely reported. Their complexity is further exemplified by the fact that several cytokines display redundancy in their receptor usage, with the recently identified IL-12 and IL-10 families being prototypical examples. Several aspects - including kinetics of expression, mode of induction, regulation of receptor expression and competition for occupancy, and the stage (acute vs chronic) of the disease - are critical to the net effect, and all these aspects need to be understood if we are to define a cytokine's whole nature.
AB - Cytokines are critical mediators in autoimmunity and a better understanding of their mode of action should contribute to the development of strategies for controlling harmful autoimmune reactions. Their complicated nature makes it difficult to classify them as pro- or anti-inflammatory mediators; redundancy in their mode of action has been widely reported. Their complexity is further exemplified by the fact that several cytokines display redundancy in their receptor usage, with the recently identified IL-12 and IL-10 families being prototypical examples. Several aspects - including kinetics of expression, mode of induction, regulation of receptor expression and competition for occupancy, and the stage (acute vs chronic) of the disease - are critical to the net effect, and all these aspects need to be understood if we are to define a cytokine's whole nature.
UR - http://www.scopus.com/inward/record.url?scp=0242407712&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0242407712&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2003.09.006
DO - 10.1016/j.coi.2003.09.006
M3 - Review article
C2 - 14630205
AN - SCOPUS:0242407712
SN - 0952-7915
VL - 15
SP - 697
EP - 703
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 6
ER -